Acceleron Pharma, Inc
Merck & Co., Inc. is a global healthcare company dedicated to discovering, developing, and providing innovative medicines, vaccines, and health solutions. With a history spanning over 130 years, Merck operates responsibly to enable a safe and healthy future for people and communities worldwide. The company is committed to scientific innovation, sustainability, and improving access to healthcare. Merck's mission is to solve some of the world's biggest health challenges through science and innovation.
Industries
Nr. of Employees
large (251-1000)
Acceleron Pharma, Inc
Cambridge, Massachusetts, United States, North America
Products
Pharmaceutical pipeline (small molecules, biologics, vaccines)
A disclosed portfolio of investigational and approved therapeutics across oncology, vaccines, infectious diseases, cardio‑metabolic disorders, immunology, neuroscience and ophthalmology.
Access and licensing programs for medicines
Programs and agreements to expand access to medicines, including voluntary licensing with generic manufacturers and patient assistance information.
Pharmaceutical pipeline (small molecules, biologics, vaccines)
A disclosed portfolio of investigational and approved therapeutics across oncology, vaccines, infectious diseases, cardio‑metabolic disorders, immunology, neuroscience and ophthalmology.
Access and licensing programs for medicines
Programs and agreements to expand access to medicines, including voluntary licensing with generic manufacturers and patient assistance information.
Services
Collaborative research and licensing
Research collaborations, exclusive licenses and co-development agreements with biotech and academic partners to discover and advance therapeutic candidates.
Clinical trial conduct and management
Operational support for planning and running clinical studies across therapeutic areas, including trial listings and patient recruitment resources.
Strategic investment and data partnerships
Equity investments and strategic relationships with data and informatics companies to support oncology research and care-improvement initiatives.
Data and biospecimen platform collaborations
Partnerships to integrate clinical records with linked biospecimens and analytic platforms to support target discovery and translational research.
Biocatalysis and enzyme engineering partnerships
Collaborative programs to engineer enzymes for use as biocatalysts and integrate them into API manufacturing workflows.
Functional discovery collaborations
Collaborative use of functional/phenotypic screening platforms to discover and validate modulators of therapeutic targets for oncology and neurology programs.
Collaborative research and licensing
Research collaborations, exclusive licenses and co-development agreements with biotech and academic partners to discover and advance therapeutic candidates.
Clinical trial conduct and management
Operational support for planning and running clinical studies across therapeutic areas, including trial listings and patient recruitment resources.
Strategic investment and data partnerships
Equity investments and strategic relationships with data and informatics companies to support oncology research and care-improvement initiatives.
Data and biospecimen platform collaborations
Partnerships to integrate clinical records with linked biospecimens and analytic platforms to support target discovery and translational research.
Biocatalysis and enzyme engineering partnerships
Collaborative programs to engineer enzymes for use as biocatalysts and integrate them into API manufacturing workflows.
Functional discovery collaborations
Collaborative use of functional/phenotypic screening platforms to discover and validate modulators of therapeutic targets for oncology and neurology programs.
Expertise Areas
- Clinical trial management
- Diversity in clinical research
- AI-driven drug discovery and generative AI
- Antibody and protein therapeutic development
Key Technologies
- Generative AI / GenAI for target and candidate design
- Machine learning/deep learning for antibody and protein design
- Synthetic biology for therapeutic engineering
- Oligonucleotide discovery platforms